Market Cap 20.87B
Revenue (ttm) 9.87B
Net Income (ttm) 871.00M
EPS (ttm) N/A
PE Ratio 19.34
Forward PE 19.09
Profit Margin 8.82%
Debt to Equity Ratio 0.78
Volume 923,800
Avg Vol 985,590
Day's Range N/A - N/A
Shares Out 111.24M
Stochastic %K 72%
Beta 0.58
Analysts Sell
Price Target $198.71

Company Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 973 520 2700
Address:
500 Plaza Drive, Secaucus, United States
PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:57 PM
$DGX is currently trading at $186.95, showing a strong position above its 30-day (MA30) and 50-day (MA50) moving averages of $182.36 and $182.94, respectively. The RSI at 61.93 indicates bullish momentum but is approaching overbought territory, suggesting caution. The recent 60-day high of $197.55 provides a potential resistance level, while the low of $174.33 indicates a solid support range. Given this context, the directional bias is bullish, supported by the price action above key moving averages and the recent high. Suggested entry point: $187.50, slightly above the last close to confirm upward momentum. Stop loss: $183.50, below the MA30 to limit risk. Target 1: $195.00, near the 60D high. Target 2: $200.00, a psychological level. Monitor RSI for signs of reversal as price approaches targets. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:31 AM
$DGX: The last close at $187.58 indicates a strong position above the 30-day MA of $182.11 and the 50-day MA of $182.88, suggesting bullish momentum. The RSI at 59.21 is approaching overbought territory but remains below 70, indicating potential for further upward movement. The 60-day high of $197.55 provides a resistance level, while the low of $174.33 establishes a support range. Directional bias is bullish due to the price being above key moving averages and the RSI indicating strength without being overextended. Suggested entry is at $188.00, with a stop loss at $183.00 to manage risk. Target 1 is set at $195.00, near the 60-day high, and Target 2 at $200.00, providing a psychological milestone. This plan leverages current market conditions and technical indicators for a calculated approach. https://privateprofiteers.com
0 · Reply
notreload_ai
notreload_ai Nov. 13 at 5:09 PM
$HIMS , $DGX , $LH ... Hims & Hers Health launches lab testing with Quest Diagnostics, offering affordable biomarker tests and personalized health plans as part of its preventive care expansion. https://notreload.xyz/hims-launches-affordable-lab-testing/
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:37 AM
$DGX: The last close at $187.9 indicates a strong position within the recent trading range, with the 60D high at $197.55 and low at $174.33. The RSI at 61.7 suggests the stock is approaching overbought territory but is not yet overextended, indicating potential for further upside. The MA30 at $181.7 and MA50 at $182.56 indicate bullish momentum, as the current price is above both moving averages. Directional bias is bullish due to the price being above key MAs and the RSI indicating strength. Suggested entry: $188.5 (slightly above the last close to confirm momentum). Stop: $184 (below recent support levels). Targets: $195 (near the 60D high) and $200 (psychological level). Monitor for any changes in market conditions or volatility. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:14 AM
$DGX: The last close at $187.9 indicates a strong position within the recent trading range, with the 60D high at $197.55 and low at $174.33. The RSI at 61.7 suggests the stock is approaching overbought territory but is not yet overextended, indicating potential for further upside. The MA30 at $181.7 and MA50 at $182.56 indicate bullish momentum, as the current price is above both moving averages. Directional bias is bullish due to the price being above key MAs and the RSI indicating strength. Suggested entry: $188.5 (slightly above the last close to confirm momentum). Stop: $184 (below recent support levels). Targets: $195 (near the 60D high) and $200 (psychological level). Monitor for any changes in market conditions or volatility. https://privateprofiteers.com
0 · Reply
NVDAMillionaire
NVDAMillionaire Nov. 3 at 6:46 PM
$DGX Outstanding article that hits the mark on DGX's current state. So if you want to refresh your DGX insights or learn about DGX from scratch, this is a must read. https://beyondspx.com/quote/DGX/analysis/quest-diagnostics-accelerating-growth-with-advanced-diagnostics-and-strategic-market-capture-dgx
0 · Reply
Halo202
Halo202 Nov. 2 at 9:47 PM
$DGX $180+ by Friday
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 31 at 12:17 PM
$DGX RSI: 36.45, MACD: -1.2211 Vol: 4.17, MA20: 182.43, MA50: 182.13 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 31 at 11:53 AM
$DGX Share Price: $175.84 Contract Selected: Feb 20, 2026 $175 Calls Buy Zone: $7.61 – $9.40 Target Zone: $12.22 – $14.94 Potential Upside: 52% ROI Time to Expiration: 111 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
prismmarketview
prismmarketview Oct. 27 at 6:38 PM
(NYSE: $DGX) Quest Diagnostics reported its AD-Detect Alzheimer’s blood tests show 91% sensitivity and specificity, matching more invasive methods for identifying brain markers. https://prismmarketview.com/quest-diagnostics-posts-strong-study-results-for-its-ad-detect-alzheimers-blood-tests/
0 · Reply
Latest News on DGX
Digi Power X Inc. (DGX:CA) Q3 2025 Earnings Call Transcript

Nov 14, 2025, 10:31 AM EST - 16 hours ago

Digi Power X Inc. (DGX:CA) Q3 2025 Earnings Call Transcript

DGXX


Quest Diagnostics Declares Quarterly Cash Dividend

Nov 11, 2025, 4:22 PM EST - 3 days ago

Quest Diagnostics Declares Quarterly Cash Dividend


Quest Diagnostics: Investing In Healthcare's Future Today

Oct 6, 2025, 12:49 AM EDT - 5 weeks ago

Quest Diagnostics: Investing In Healthcare's Future Today


Quest Diagnostics Introduces Testing for Oropouche Virus

Jul 15, 2025, 7:57 AM EDT - 4 months ago

Quest Diagnostics Introduces Testing for Oropouche Virus


Quest Diagnostics Releases 2024 Corporate Responsibility Report

Jun 25, 2025, 9:07 AM EDT - 5 months ago

Quest Diagnostics Releases 2024 Corporate Responsibility Report


Quest Diagnostics: A Leader But Waiting For Better Price

May 3, 2025, 4:26 AM EDT - 6 months ago

Quest Diagnostics: A Leader But Waiting For Better Price


8 Upcoming Dividend Increases During Volatile Times

Apr 4, 2025, 1:43 PM EDT - 8 months ago

8 Upcoming Dividend Increases During Volatile Times

AMT BKU GD KAI ORCL REIT RNP


PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:57 PM
$DGX is currently trading at $186.95, showing a strong position above its 30-day (MA30) and 50-day (MA50) moving averages of $182.36 and $182.94, respectively. The RSI at 61.93 indicates bullish momentum but is approaching overbought territory, suggesting caution. The recent 60-day high of $197.55 provides a potential resistance level, while the low of $174.33 indicates a solid support range. Given this context, the directional bias is bullish, supported by the price action above key moving averages and the recent high. Suggested entry point: $187.50, slightly above the last close to confirm upward momentum. Stop loss: $183.50, below the MA30 to limit risk. Target 1: $195.00, near the 60D high. Target 2: $200.00, a psychological level. Monitor RSI for signs of reversal as price approaches targets. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:31 AM
$DGX: The last close at $187.58 indicates a strong position above the 30-day MA of $182.11 and the 50-day MA of $182.88, suggesting bullish momentum. The RSI at 59.21 is approaching overbought territory but remains below 70, indicating potential for further upward movement. The 60-day high of $197.55 provides a resistance level, while the low of $174.33 establishes a support range. Directional bias is bullish due to the price being above key moving averages and the RSI indicating strength without being overextended. Suggested entry is at $188.00, with a stop loss at $183.00 to manage risk. Target 1 is set at $195.00, near the 60-day high, and Target 2 at $200.00, providing a psychological milestone. This plan leverages current market conditions and technical indicators for a calculated approach. https://privateprofiteers.com
0 · Reply
notreload_ai
notreload_ai Nov. 13 at 5:09 PM
$HIMS , $DGX , $LH ... Hims & Hers Health launches lab testing with Quest Diagnostics, offering affordable biomarker tests and personalized health plans as part of its preventive care expansion. https://notreload.xyz/hims-launches-affordable-lab-testing/
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:37 AM
$DGX: The last close at $187.9 indicates a strong position within the recent trading range, with the 60D high at $197.55 and low at $174.33. The RSI at 61.7 suggests the stock is approaching overbought territory but is not yet overextended, indicating potential for further upside. The MA30 at $181.7 and MA50 at $182.56 indicate bullish momentum, as the current price is above both moving averages. Directional bias is bullish due to the price being above key MAs and the RSI indicating strength. Suggested entry: $188.5 (slightly above the last close to confirm momentum). Stop: $184 (below recent support levels). Targets: $195 (near the 60D high) and $200 (psychological level). Monitor for any changes in market conditions or volatility. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:14 AM
$DGX: The last close at $187.9 indicates a strong position within the recent trading range, with the 60D high at $197.55 and low at $174.33. The RSI at 61.7 suggests the stock is approaching overbought territory but is not yet overextended, indicating potential for further upside. The MA30 at $181.7 and MA50 at $182.56 indicate bullish momentum, as the current price is above both moving averages. Directional bias is bullish due to the price being above key MAs and the RSI indicating strength. Suggested entry: $188.5 (slightly above the last close to confirm momentum). Stop: $184 (below recent support levels). Targets: $195 (near the 60D high) and $200 (psychological level). Monitor for any changes in market conditions or volatility. https://privateprofiteers.com
0 · Reply
NVDAMillionaire
NVDAMillionaire Nov. 3 at 6:46 PM
$DGX Outstanding article that hits the mark on DGX's current state. So if you want to refresh your DGX insights or learn about DGX from scratch, this is a must read. https://beyondspx.com/quote/DGX/analysis/quest-diagnostics-accelerating-growth-with-advanced-diagnostics-and-strategic-market-capture-dgx
0 · Reply
Halo202
Halo202 Nov. 2 at 9:47 PM
$DGX $180+ by Friday
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 31 at 12:17 PM
$DGX RSI: 36.45, MACD: -1.2211 Vol: 4.17, MA20: 182.43, MA50: 182.13 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 31 at 11:53 AM
$DGX Share Price: $175.84 Contract Selected: Feb 20, 2026 $175 Calls Buy Zone: $7.61 – $9.40 Target Zone: $12.22 – $14.94 Potential Upside: 52% ROI Time to Expiration: 111 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
prismmarketview
prismmarketview Oct. 27 at 6:38 PM
(NYSE: $DGX) Quest Diagnostics reported its AD-Detect Alzheimer’s blood tests show 91% sensitivity and specificity, matching more invasive methods for identifying brain markers. https://prismmarketview.com/quest-diagnostics-posts-strong-study-results-for-its-ad-detect-alzheimers-blood-tests/
0 · Reply
Bazzzigar
Bazzzigar Oct. 24 at 10:59 PM
$DGX hold long term
0 · Reply
Bazzzigar
Bazzzigar Oct. 24 at 6:23 PM
$DGX few more
0 · Reply
Small_time_trader
Small_time_trader Oct. 22 at 7:36 PM
$DGX Don’t sweat PAMA If PAMA is not delayed, many smaller labs instantly would be non - profitable and close their doors, big commercial labs like DGX would swoop in and grab the work. most likely Pama will continue to be pushed out until substantial changes are made to the pieces impacting laboratory medicine. Either way DGX wins
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 4:59 PM
Barclays has adjusted their stance on Quest Diagnostics ( $DGX ), setting the rating to Equal-Weight with a target price of 190 → 195.
0 · Reply
Bazzzigar
Bazzzigar Oct. 22 at 3:13 PM
$DGX sector up
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 2:09 PM
Truist Securities updates rating for Quest Diagnostics ( $DGX ) to Hold, target set at 195 → 205.
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 8:57 PM
Leerink Partners has updated their rating for Quest Diagnostics ( $DGX ) to Outperform with a price target of 210.
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 8:39 PM
Jefferies updates rating for Quest Diagnostics ( $DGX ) to Buy, target set at 200 → 215.
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 8:37 PM
Jefferies has updated their rating for Quest Diagnostics ( $DGX ) to Buy with a price target of 200.
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 21 at 7:46 PM
$DGX Share Price: $184.70 Contract Selected: Feb 20, 2026 $185 Calls Buy Zone: $7.48 – $9.24 Target Zone: $13.89 – $16.98 Potential Upside: 75% ROI Time to Expiration: 121 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Small_time_trader
Small_time_trader Oct. 21 at 4:37 PM
$DGX Folks this was a good ole fashioned beat and raise with up beat messaging and feel. This dip in price IS A GIFT Expect it to go higher all day and quickly get back to 190 price
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 21 at 4:23 PM
0 · Reply